OVERVIEW

RENALC-BLADDR-PROSCA 2025 Hybrid Global Forum on GU Oncology is organized by International Society for the Study and Exchange of evidence from Clinical research And Medical experience (ISSECAM) and will be held from Dec 03 - 06, 2025 at EPIC SANA Lisboa Hotel, Lisbon, Portugal.

RENALC: 3 December 2025 (08:30 – 14:00)
BLADDR: 3  December 2025 (12:30 – 18:00) & 4 December 2025 (08:30 – 17:30)
PROSCA: 5 December 2025 (08:30 – 18:00) & 6 December 2025 (08:30 – 15:30)

Why Should You Attend?
The hybrid Global forum is a unique highly interactive meeting using the Mirrors of Medicine™ educational method. During this meeting you will be able to interact in depth with a top faculty and your peers on how to apply the 2025 evidence into your clinical practice.

KEY DATES

Event Start Date
03 Dec, 2025
Event Start Date
Event End Date
06 Dec, 2025
Event End Date
Credits

CME Accreditation
RENALC 2025
The RENALC 2025 – Global Forum on Renal cell Cancer (2nd edition), Lisbon & hybrid, Portugal 3/12/2025, has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 3.5 European CME credits (ECMEC®s). Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.

Through an agreement between the Union Européenne des Médecins Spécialistes and the American Medical Association, physicians may convert EACCME® credits to an equivalent number of AMA PRA Category 1 CreditsTM.

Live educational activities, occurring outside of Canada, recognised by the UEMS-EACCME® for ECMEC®s are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada

BLADDR 2025
The BLADDR 2025 – Global Forum on Bladder Cancer (10th edition), Lisbon & hybrid, Portugal 03/12/2025 – 04/12/2025, has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 11.0 European CME credits (ECMEC®s). Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.

Through an agreement between the Union Européenne des Médecins Spécialistes and the American Medical Association, physicians may convert EACCME® credits to an equivalent number of AMA PRA Category 1 CreditsTM.

Live educational activities, occurring outside of Canada, recognised by the UEMS-EACCME® for ECMEC®s are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada

PROSCA 2025
The PROSCA 2025 – Global Forum on Prostate Cancer (13th edition), Lisbon & hybrid, Portugal 5/12/2025 – 06/12/2025, has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 10.0 European CME credits (ECMEC®s). Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.

Through an agreement between the Union Européenne des Médecins Spécialistes and the American Medical Association, physicians may convert EACCME® credits to an equivalent number of AMA PRA Category 1 CreditsTM.

Live educational activities, occurring outside of Canada, recognised by the UEMS-EACCME® for ECMEC®s are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada.

  • 11 ECMECs
  • TARGET AUDIENCE

    PhysicianNursingStudentsOncologistsResidentsTechnicians

    SPECIALITIES

    Oncology

    SUGGESTED HOTELS

    CONFERENCE VENUE

    LocationEPIC SANA Lisboa Hotel
    Av. Eng. Duarte Pacheco 15

    RELATED CONFERENCES & LIVE WEBINARS

    Feb 01 - 02, 2027 | Dubai, Dubai, UAE

    Oncology
    30 CME
    ...
    More actions
    GB£19

    Feb 01 - 02, 2027 | Dubai, Dubai, UAE

    Pathology
    30 CME
    ...
    More actions
    GB£45

    Oct 29 - 30, 2026 | Orlando, Florida, USA

    Oncology
    More actions
    US$235